Celera Revenue and Competitors
Estimated Revenue & Valuation
- Celera's estimated annual revenue is currently $4M per year.
- Celera's estimated revenue per employee is $192,500
Employee Data
- Celera has 21 Employees.
- Celera grew their employee count by 17% last year.
Celera's People
| Name | Title | Email/Phone |
|---|
Celera Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4M | 21 | -5% | N/A | N/A |
#2 | $4.4M | 23 | -12% | N/A | N/A |
#3 | $27.2M | 99 | -7% | N/A | N/A |
#4 | $6.8M | 31 | -14% | N/A | N/A |
#5 | $4.6M | 24 | -4% | N/A | N/A |
#6 | $139.6M | 406 | -6% | N/A | N/A |
#7 | $16.6M | 67 | 5% | N/A | N/A |
#8 | $12.9M | 0 | N/A | $11M | N/A |
#9 | $1252.4M | 3253 | -3% | N/A | N/A |
#10 | $323.7M | 2312 | 2% | N/A | N/A |
What Is Celera?
Liberating the analog/mixed-signal IC industry by improving R&D efficiency 100X. Celera delivers the 'impossible': fully automated analog/mixed-signal IC development lightning fast and the push of a button. This unburdens the industry to pursue an estimated $30B in new profitable growth ushering the next generation of semiconductor devices: Silicon 3.0 - Move Fast and Build Things.
keywords:N/A
N/A
Total Funding
21
Number of Employees
$4M
Revenue (est)
17%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Celera News
Unlike many of today's eVTOLs and other aircraft concepts that were put together in a relatively short time, the Celera's story goes way...
Abbott, Celera Group, Elitech Group, PerkinElmer, Quest Diagnostics, AutoGenomics, Roche Diagnostics, BioRad, Transgenomic,...
Celera Group, Abbott Laboratories, ELITech Group, Quest Diagnostics, AutoGenomics, PerkinElmer, Roche Diagnostics, Bio-Rad Laboratories,...
Other Companies in San Jose
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $2.8M | 21 | -9% | $41M |
#2 | $5.3M | 21 | -5% | $138.9M |
#3 | $3M | 21 | -5% | N/A |
#4 | $3M | 21 | 5% | N/A |
#5 | $3M | 21 | 5% | N/A |